Professor Kranzler is the Benjamin Rush Professor of Psychiatry and Director of the Center for Studies of Addiction at the University of Pennsylvania’s Perelman School of Medicine Tel Aviv, Israel / Vancouver, Canada, March 14, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (CSE: CMND), (FSE: CWY) (“Clearmind” or the “company”), a biotech company focused on discovery and…

Source

Previous articleBetterLife Closes $1,857,143 of Private Placement
Next articlePT398 – Lost Civilizations, DMT Entities, & Altered States of Consciousness and Early Religion